查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678747

全球医院感染诊断市场：市场规模、份额、趋势分析（按检测、感染疾病、产品、类型和地区）、细分市场预测（2025-2030 年）

Hospital Acquired Infections Diagnostics Market Size, Share & Trends Analysis Report By Test (Molecular, Conventional), By Infection (UTI, Pneumonia), By Product, By Type, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10个工作天内

价格

医院感染诊断市场的成长与趋势：

根据 Grand View Research, Inc. 的一份新报告，全球医院感染诊断市场预计到 2030 年将达到 47.4 亿美元。

预计 2025 年至 2030 年期间，全球医院感染诊断市场将以 1.49% 的健康复合年增长率成长。推动市场成长的因素包括抗药性病原体（如 MRSA 和艰难梭菌）的增加、老年人口的老化，以及提供准确、可靠结果和快速週转时间的技术先进产品的开发。

推动产业成长的另一个因素是中低收入国家对 HAI 诊断的需求不断增加，这进一步推动了 HAI 诊断市场的需求。医疗保健专业人士的意识不断提高和政府提案的倡议进一步推动了该行业的发展。然而，已开发国家医院内感染盛行率的下降可能会阻碍该产业的发展。

医院获得性感染 (HAI) 诊断市场根据感染疾病类型和测试类型进行细分。感染依类型分为尿道感染(UTI)、血流感染 (BSI)、手术部位感染 (SSI)、肺炎等。截至 2015 年，尿道感染领域估计占最大份额，而肺炎 HAI 诊断预计在 2025-2030 年期间以最高复合年增长率增长。医院感染诊断产业进一步细分为分子测试和其他体外测试。医院感染诊断产业进一步细分为分子测试和其他体外测试。儘管分子诊断的份额较低，但预计未来几年将呈现良好成长。

医院感染诊断市场：分析概述

  • 预计消耗品部门将在 2024 年占据最大的收益占有率，并预计在预测期内以 1.55% 的最快复合年增长率成长。
  • 血液检测部门将在 2024 年占据最大的收益占有率，预计在预测期内以 1.55% 的最快复合年增长率增长。
  • 欧洲将主导市场，到 2024 年将占据 34.57% 的最大收益占有率。这是由于疾病负担重、基础设施可用、医疗保健支出增加、技术进步迅速、政府积极主动的倡议、患者意识的不断增强以及主要企业的存在。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3 章医院感染诊断市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 渗透和成长前景规划
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
    • 市场机会
    • 市场挑战
  • 医院感染诊断市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL 分析

第 4 章 医院内感染的诊断：按检测类型分類的估计值和趋势

  • 医院感染诊断市场：关键要点
  • 医院感染诊断市场：趋势和市场占有率分析（2022 年和 2030 年）
  • 传统的
    • 2018 年至 2030 年的市场估计与预测
  • 分子
    • 2018 年至 2030 年分子市场估计与预测

第 5 章 医院内感染的诊断：感染疾病的估计和趋势

  • 医院感染诊断市场：关键要点
  • 医院感染诊断市场：趋势和市场占有率分析（2022 年和 2030 年）
  • 尿道感染(UTI)
    • 2018 年至 2030 年 UTI 市场估计与预测
  • 肺炎
    • 2018 年至 2030 年肺炎市场估计与预测
  • 手术部位感染
    • 2018 年至 2030 年手术部位感染市场估计与预测
  • 血流感染疾病
    • 2018 年至 2030 年血流感染疾病市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他感染疾病市场估计与预测

第 6 章 医院感染诊断：按产品分类的估计和趋势分析

  • 医院感染诊断市场：关键要点
  • 医院感染诊断市场：趋势和市场占有率分析（2022 年和 2030 年）
  • 耗材
    • 2018 年至 2030 年消耗品市场估计与预测
  • 装置
    • 2018 年至 2030 年设备市场估计与预测

第 7 章医院感染诊断市场：按类型估计和趋势分析

  • 医院感染诊断市场：关键要点
  • 按类型展望
  • 血液检查
  • 尿液检查

第 8 章医院感染诊断市场：按地区分類的估计和趋势分析

  • 区域展望
  • 医院感染疾病诊断市场：按地区分類的关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 公司市场占有率分析（2024 年）
  • 公司简介
    • BIOMERIEUX
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthcare Private Limited
    • BD（Becton, Dickinson and Company）
    • Hologic, Inc.
    • Meridian Bioscience, Inc
    • QIAGEN
    • Thermo Fisher Scientific Inc.
    • Bioscience, Inc.
Product Code: 978-1-68038-783-4

Hospital Acquired Infections Diagnostics Market Growth & Trends:

The global hospital acquired infections diagnostics market size is expected to reach USD 4.74 billion by 2030, according to a new report by Grand View Research, Inc. The global hospital acquired infections diagnostics market is projected to grow at a healthy CAGR of 1.49% during the period of 2025 to 2030. Factors attributing to the growth of the market are increase in the number of drug-resistant pathogens such as MRSA and C. difficile, advancing age of geriatric population, and development of technologically advanced products that offer accurate and reliable results with low turnaround time.

Another factor contributing to industry growth is the increasing demand of HAI diagnostics from middle and low income countries, further driving demand for HAI diagnostic market. Increasing awareness among healthcare workers and proposed government initiatives are further supporting industry growth. However, decline in the prevalence rate of nosocomial infections in the developed countries is likely to hinder industry growth.

The HAI diagnostics market is categorized on the basis of infection type and test type. On the basis of infection type, the market is segmented into Urinary Tract Infection (UTI), Blood Stream Infection (BSI), Surgical Site Infection (SSI), pneumonia, and others. As of 2015, the urinary tract infection segment was estimated to account for the largest share, whereas the pneumonia HAI diagnostics is projected to grow at the highest CAGR during the period of 2025 to 2030.The HAI diagnostics industry is further segmented into molecular tests and other in-vitro tests. Though the molecular diagnostics segment is estimated to constitute a low share, it is anticipated to witness a lucrative growth in the next few years.

Hospital Acquired Infections Diagnostics Market Report Highlights:

  • The consumables segment held the largest revenue share in 2024 and is expected to grow at the fastest CAGR of 1.55% over the forecast period,
  • The blood tests segment held the largest revenue share in 2024 and is expected to grow at the fastest CAGR of 1.55% during the forecast period
  • Europe dominated the market and accounted for the largest revenue share of 34.57% in 2024, owing to the high disease burden, the availability of infrastructure, increased healthcare expenditure, rapid technological advancements, proactive government initiatives, rise in patient awareness, and the presence of major players.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test
    • 1.1.2. Infection
    • 1.1.3. Product
    • 1.1.4. Type
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. Infection outlook
    • 2.2.3. Product outlook
    • 2.2.4. Type outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hospitals Acquired Infections Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Hospitals Acquired Infections Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Hospitals Acquired Infections Diagnostics: Test Estimates & Trend Analysis

  • 4.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 4.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Conventional
    • 4.3.1. Conventional market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Molecular
    • 4.4.1. Molecular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hospital Acquired Infections Diagnostics: Infection Estimates & Trend Analysis

  • 5.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 5.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. UTI
    • 5.3.1. UTI market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Pneumonia
    • 5.4.1. Pneumonia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Surgical Site Infection
    • 5.5.1. Surgical site infection market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Blood Stream Infections
    • 5.6.1. Blood stream infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others infections market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hospital Acquired Infections Diagnostics: Product Estimates & Trend Analysis

  • 6.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 6.2. Hospital Acquired Infections Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Consumables
    • 6.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Instruments
    • 6.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Hospital Acquired Infections Diagnostics Market: Type Estimates & Trend Analysis

  • 7.1. Hospital Acquired Infections Diagnostics Market: Key Takeaways
  • 7.2. Type Outlook
    • 7.2.1. Type Outlook market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3. Blood Tests
    • 7.3.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Urinalysis
    • 7.4.1. Urinalysis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Hospital Acquired Infections Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Hospitals Acquired Infections Diagnostics Market by Region: Key Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key Country Dynamics
      • 8.4.1.2. Competitive Scenario
      • 8.4.1.3. Regulatory Framework
      • 8.4.1.4. Reimbursement Scenario
      • 8.4.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Denmark
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key Country Dynamics
      • 8.5.1.2. Competitive Scenario
      • 8.5.1.3. Regulatory Framework
      • 8.5.1.4. Reimbursement Scenario
      • 8.5.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key Country Dynamics
      • 8.6.1.2. Competitive Scenario
      • 8.6.1.3. Regulatory Framework
      • 8.6.1.4. Reimbursement Scenario
      • 8.6.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key Country Dynamics
      • 8.7.1.2. Competitive Scenario
      • 8.7.1.3. Regulatory Framework
      • 8.7.1.4. Reimbursement Scenario
      • 8.7.1.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. BIOMERIEUX
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Abbott
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. F. Hoffmann-La Roche Ltd
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Siemens Healthcare Private Limited
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. BD (Becton, Dickinson and Company)
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Hologic, Inc.
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Meridian Bioscience, Inc
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. QIAGEN
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Thermo Fisher Scientific Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Bioscience, Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 3 North America hospital acquired infections diagnostics market, by infection Type, 2018 - 2030 (USD Million)
  • Table 4 North America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 6 North America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 8 U.S. hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 9 U.S. hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 12 Canada hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 13 Canada hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 15 Mexico hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 16 Mexico hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 17 Mexico hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 18 Mexico hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Europe hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 20 Europe hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 21 Europe hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 23 UK hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 24 UK hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 25 UK hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 28 Germany hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 29 Germany hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 31 France hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 32 France hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 33 France hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 France hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 35 Italy hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 36 Italy hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 37 Italy hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 39 Spain hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 40 Spain hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 41 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Denmark hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 44 Denmark hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 45 Denmark hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Sweden hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 48 Sweden hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 49 Sweden hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Norway hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 52 Norway hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 53 Norway hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Norway hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 60 Japan hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 61 Japan hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 62 Japan hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Japan hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 64 China hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 65 China hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 66 China hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 China hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 68 India hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 69 India hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 70 India hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 India hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 72 Australia hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 73 Australia hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 74 Australia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 Australia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 76 Thailand hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 77 Thailand hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 78 Thailand hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Thailand hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Korea hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 81 South Korea hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 82 South Korea hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Korea hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 84 Latin America hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 85 Latin America hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 86 Latin America hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Latin America hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 88 Latin America hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 89 Brazil hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 90 Brazil hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 91 Brazil hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 93 Argentina hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 94 Argentina hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 95 Argentina hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Argentina hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 97 Middle East and Africa hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa hospital acquired infections diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 102 South Africa hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 103 South Africa hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 104 South Africa hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 South Africa hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 110 UAE hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 111 UAE hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 112 UAE hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 UAE hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 114 Kuwait hospital acquired infections diagnostics market, by test, 2018 - 2030 (USD Million)
  • Table 115 Kuwait hospital acquired infections diagnostics market, by infection, 2018 - 2030 (USD Million)
  • Table 116 Kuwait hospital acquired infections diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 Kuwait hospital acquired infections diagnostics market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Microneedle Instruments systems: market outlook
  • Fig. 8 Hospital Acquired Infections Diagnostics competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Hospital acquired infections diagnostics market driver impact
  • Fig. 13 Hospital acquired infections diagnostics market restraint impact
  • Fig. 14 Hospital acquired infections diagnostics market strategic initiatives analysis
  • Fig. 15 Hospital acquired infections diagnostics market: Test type movement analysis
  • Fig. 16 Hospital acquired infections diagnostics market: Test type outlook and key takeaways
  • Fig. 17 Molecular market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Conventional market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Hospital acquired infections diagnostics market: Infection type movement analysis
  • Fig. 20 Hospital acquired infections diagnostics market: Infection type outlook and key takeaways
  • Fig. 21 UTI market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pneumonia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Surgical site infection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Blood stream infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Hospital acquired infections diagnostics market: Product movement analysis
  • Fig. 27 Hospital acquired infections diagnostics market: Product outlook and key takeaways
  • Fig. 28 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 2030 Hospital Acquired Infections Diagnostics market: Type outlook and key takeaways
  • Fig. 31 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Urinalysis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Global hospital acquired infections diagnostics market: Regional movement analysis
  • Fig. 35 Global hospital acquired infections diagnostics market: Regional outlook and key takeaways
  • Fig. 36 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)